The document provides an overview of key trends in the global healthcare investment landscape in Q1 2020. Some of the main findings include:
- North American healthcare companies raised $10.3B in funding in Q1, setting a new record high driven by 25 mega-rounds.
- There are now 42 healthcare unicorns globally worth a combined $101.5B.
- Global digital health funding declined 8% to $4.5B in Q1 while deals fell 4% due to declines in China.
- Telehealth deals reached a record high of 103 in Q1 amid increased focus on virtual care during the COVID-19 pandemic.
StartUp Health - Private Market Perspectives - Digital Healthcare Innovation ...Healthegy
Presentation by StartUp Health at Digital Healthcare Innovation Summit 2016.
Participant:
Katya Hancock, Director of Strategic Partnerships – StartUp Health
Introduced By:
Tom Salemi, Content Director – Healthegy
Powered by:
Healthegy
For more healthcare innovation
Visit us at Healthegy.com
Top 12 Venture Capital Firms Funding the 50+ MarketSanjay Khurana
Report takes a closer look at the top venture capitalists in 50+ investing in Digital Health and the areas and the areas with health they like to invest in.
In our annual Healthcare Investments and Exits report, SVB analyzed the fundraising, investment, M&A and IPO activity of private, venture-backed biopharma, medical device and diagnostic/tools companies.
StartUp Health Insights Funding Report Q1 2017StartUp Health
If the first quarter of 2017 is any indication of what’s to come, 2017 is going to be another important year for digital health funding. Among this quarter’s most notable developments, the population health sector saw a large number of deals, Los Angeles emerged as a hotspot of digital health funding, and cancer detection ‘startup’ GRAIL had a record-breaking Series B further displaying the inevitable trend of ‘digital’ weaving into the fabric of every other health/healthcare sector.
2016 is on track to be the biggest year yet for digital health funding. Q3 was significant with almost $2.4B in deals, nearly half of which were international. We continue to see the market expand globally, with several large deals taking place both in the US and overseas.
A Defining Moment for Digital Behavioral Health- FOUR MARKET TRENDS. Presentation by Megan Zweig, Rock Health, for mHealth Israel, March 24, 2021. 2020 was the biggest year yet for digital behavioral health companies, exceeding the previous record set in 2018 in deal count, funding, and average deal size.
TREND #1:
Investors are supporting early- and latestage innovation, though an increasing amount of capital is being put to work in later-stage deals to ensure mature products can scale to meet urgent demand.
Though most behavioral health funding has gone to larger, later-stage rounds, most deals have been early-stage. While the average deal size for early-stage deals has held relatively constant, the average deal size for later-stage deals has doubled in size over the past five years.
TREND #2:
There’s room for both generalist and specialist models to meet high and diverse behavioral health demand.
Amwell is the top-funded company supporting behavioral health and other conditions; Lyra is the top-funded startup exclusively focused on behavioral health. “Generalist" companies led the pack in 2020 with $1.6B in funding, while $804.3M was raised by startups exclusively focused on behavioral health (“specialists”). Five “generalist” companies have gone public; in 2021, TalkSpace will be the first company exclusively focused on behavioral health to go public,
TREND #3:
Consolidation for clinical and digital capabilities has sped up and will likely continue.
There were nine digital behavioral health M&A deals in 2020, far exceeding the amount from any previous year.
TREND #4:
The relatively low flow of capital to SUDs and developmental disorders compared to mental health signals an opportunity for
innovators and investors.
Startups exclusively focused on mental health have seen more funding and deals than those focused on substance use disorders and developmental disorders.
StartUp Health - Private Market Perspectives - Digital Healthcare Innovation ...Healthegy
Presentation by StartUp Health at Digital Healthcare Innovation Summit 2016.
Participant:
Katya Hancock, Director of Strategic Partnerships – StartUp Health
Introduced By:
Tom Salemi, Content Director – Healthegy
Powered by:
Healthegy
For more healthcare innovation
Visit us at Healthegy.com
Top 12 Venture Capital Firms Funding the 50+ MarketSanjay Khurana
Report takes a closer look at the top venture capitalists in 50+ investing in Digital Health and the areas and the areas with health they like to invest in.
In our annual Healthcare Investments and Exits report, SVB analyzed the fundraising, investment, M&A and IPO activity of private, venture-backed biopharma, medical device and diagnostic/tools companies.
StartUp Health Insights Funding Report Q1 2017StartUp Health
If the first quarter of 2017 is any indication of what’s to come, 2017 is going to be another important year for digital health funding. Among this quarter’s most notable developments, the population health sector saw a large number of deals, Los Angeles emerged as a hotspot of digital health funding, and cancer detection ‘startup’ GRAIL had a record-breaking Series B further displaying the inevitable trend of ‘digital’ weaving into the fabric of every other health/healthcare sector.
2016 is on track to be the biggest year yet for digital health funding. Q3 was significant with almost $2.4B in deals, nearly half of which were international. We continue to see the market expand globally, with several large deals taking place both in the US and overseas.
A Defining Moment for Digital Behavioral Health- FOUR MARKET TRENDS. Presentation by Megan Zweig, Rock Health, for mHealth Israel, March 24, 2021. 2020 was the biggest year yet for digital behavioral health companies, exceeding the previous record set in 2018 in deal count, funding, and average deal size.
TREND #1:
Investors are supporting early- and latestage innovation, though an increasing amount of capital is being put to work in later-stage deals to ensure mature products can scale to meet urgent demand.
Though most behavioral health funding has gone to larger, later-stage rounds, most deals have been early-stage. While the average deal size for early-stage deals has held relatively constant, the average deal size for later-stage deals has doubled in size over the past five years.
TREND #2:
There’s room for both generalist and specialist models to meet high and diverse behavioral health demand.
Amwell is the top-funded company supporting behavioral health and other conditions; Lyra is the top-funded startup exclusively focused on behavioral health. “Generalist" companies led the pack in 2020 with $1.6B in funding, while $804.3M was raised by startups exclusively focused on behavioral health (“specialists”). Five “generalist” companies have gone public; in 2021, TalkSpace will be the first company exclusively focused on behavioral health to go public,
TREND #3:
Consolidation for clinical and digital capabilities has sped up and will likely continue.
There were nine digital behavioral health M&A deals in 2020, far exceeding the amount from any previous year.
TREND #4:
The relatively low flow of capital to SUDs and developmental disorders compared to mental health signals an opportunity for
innovators and investors.
Startups exclusively focused on mental health have seen more funding and deals than those focused on substance use disorders and developmental disorders.
New startup investment in the healthcare sector has undergone a gradual slowdown since Q4 2018. Explore more global trends in our report on the healthcare sector here http://bit.ly/hlt_sector
StartUp Health Insights Global Digital Health Funding Report Q3 2018StartUp Health
A new benchmark has been set in the digital health market in Q3 2018, surpassing 2017 Q3 funding by almost $2B, hitting an all
time high Q3 mark of $11.1B. Record numbers of mid- and late-stage deals serve as a stabilizing force, creating market maturity
parallel to fund growth. International investments surge with Beijing as the home of five of the top ten international deals, and
European cities serving up an abundance of early-stage deals. With investors outpacing their 2017 totals, the digital health
market continues to be one of the fastest growing segments of the healthcare industry.
StartUp Health Insights Global Digital Health Funding Report: 2018 Year End R...StartUp Health
Welcome to the most-funded year ever in digital health. Investments topped hundreds of millions of US dollars for the first time, with funds funneling to a broader range of cities like Bengaluru and Nashville. Globally, investors are on track to nearly double their 2017 investments, demonstrating long-term commitments, as well as overall growth potential in the market. The digital health market is as potent as ever.
StartUp Health Insights Global Digital Health Funding Report Q1 2018StartUp Health
2018 Q1 continued the wave of digital health investment activity - the most deal volume of any first quarter since we’ve been tracking data - totaling $2.8B of investment across 191 deals. In addition, we’re seeing more deal flow at every stage, across a spectrum of companies and technologies, from an increasing ecosystem of investors.
2017 StartUp Health Insights Year End ReportStartUp Health
As predicted, digital health investment reached new heights in 2017 with $11.5B in funding across 794 deals. Looking beyond the
numbers provides insight into a sector transitioning to a more mature phase. Deal activity at the early stage has fueled a startup
wave and a maturing market with more later-stage opportunities is attracting new investment globally. 2018 is poised to be a
dynamic year in terms of digital health funding activity, M&A and breakout successes, and experimentation paving the way for
new advancements.
2018 StartUp Health Insights Global Digital Health Funding Report 2018 MidyearStartUp Health
The first half of 2018 has brought an increase in deal volume and a total of $6.1B invested in digital health companies across the globe - showing a heightened confidence in the sector.
mHealth Israel_PwC Top Health Industry Issues of 2020Levi Shapiro
Review of 2020's top healthcare issues, by Ben Isgur, Head, PwC Health Research Institute:
1) A looming tsunami of high prices
2) Regulations trumps policy
3) Consumers inch closer to DIY healthcare
4) A whole new you- deals as makeovers
5) Equity and inclusion, not just diversity, as a business imperative
6) US health organizations are seeking opportunities overseas and through innovation. Beware of the tax risks
7) Fast- forwarding from data to decisions
Healthcare executives maintain a relatively positive outlook for the upcoming year. The majority remain optimistic, expecting similar growth to last year in revenue, prices, volume and capital spending. Many other non-financial trends within the industry are also seen as having a beneficial impact on consumers and the quality of care being delivered.
For one, trends around Mergers & Acquisitions (M&A) are increasing from last year, with a general optimism about the impact, especially on the industry side, for efficiency and revenue. About three-quarters of executives also believe that increased M&A may result in a greater focus on care (over business administration.)
Second, most executives anticipate a continued--and increasing--reliance on technology that should improve quality and reduce costs. But with higher stakes, the challenge will be how to seamlessly incorporate technology industry-wide without compromising security.
Despite the optimistic tone, however, healthcare costs continue to be an untenable uphill battle for consumers, with no improvement over last year. Executives perceive that these overwhelming costs are damaging care and that many consumers may be sacrificing care to save money. Many executives claim they are working to figure out ways to alleviate this problem. In addition, executives are more open to government involvement with regulating the industry, but there is very little consensus on how to measure success and utilize outcomes.
The COVID-19 crisis is threatening the lives and well-being of the global community. Health, political, societal, and business leaders must drive an integrated response to navigate, manage, and lead through it.
Impact of covid 19 on indian stock market with reference to Pharmaceutical, I...BhaumikMajithia
The report talks about how the indian stock market is affected from COVID-19 and also for reference we have used market price trends of 9 companies like Infosys, TCS, Hero Motocorp, Tata Motors, HCL, Maruti Suzuki, Sn pharma, Panacea Biotec and Zydus Wellness.
PwC’s new Golden Age Index – how well are countries harnessing the power of o...PwC
One of the key megatrends affecting the UK and most other developed countries is an ageing population. Harnessing the potential of older workers will therefore become an increasingly important source of competitive advantage for both nations and businesses.
To explore how the UK compares with other OECD economies in this regard, PwC has developed a new ‘Golden Age index’ comparing how well they are utilising workers aged 55 and over. The index includes relative employment, earnings and training rates for older workers for 34 OECD countries over the period since 2003.
State Of Healthcare Q2’21 Report: Investment & Sector Trends To Watch. Contents include Summary, Market Drivers, Investment Trends, Sector Highlights (AI, Health IT, Omics, telehealth, digital therapeutics, mental health, medical devices, digital health, etc). Global healthcare investment rose for the seventh consecutive quarter. European investment nearly doubled. A flood of new entrants pushed early-stage deal share
above 50%. M&A activity persisted. The top healthcare deals in the quarter (by deal size) went to companies working in life sciences. The SPAC frenzy continued within digital health. Eleven healthcare startups joined the unicorn club during
Q2’21 (valued in aggregate at $27B).
New startup investment in the healthcare sector has undergone a gradual slowdown since Q4 2018. Explore more global trends in our report on the healthcare sector here http://bit.ly/hlt_sector
StartUp Health Insights Global Digital Health Funding Report Q3 2018StartUp Health
A new benchmark has been set in the digital health market in Q3 2018, surpassing 2017 Q3 funding by almost $2B, hitting an all
time high Q3 mark of $11.1B. Record numbers of mid- and late-stage deals serve as a stabilizing force, creating market maturity
parallel to fund growth. International investments surge with Beijing as the home of five of the top ten international deals, and
European cities serving up an abundance of early-stage deals. With investors outpacing their 2017 totals, the digital health
market continues to be one of the fastest growing segments of the healthcare industry.
StartUp Health Insights Global Digital Health Funding Report: 2018 Year End R...StartUp Health
Welcome to the most-funded year ever in digital health. Investments topped hundreds of millions of US dollars for the first time, with funds funneling to a broader range of cities like Bengaluru and Nashville. Globally, investors are on track to nearly double their 2017 investments, demonstrating long-term commitments, as well as overall growth potential in the market. The digital health market is as potent as ever.
StartUp Health Insights Global Digital Health Funding Report Q1 2018StartUp Health
2018 Q1 continued the wave of digital health investment activity - the most deal volume of any first quarter since we’ve been tracking data - totaling $2.8B of investment across 191 deals. In addition, we’re seeing more deal flow at every stage, across a spectrum of companies and technologies, from an increasing ecosystem of investors.
2017 StartUp Health Insights Year End ReportStartUp Health
As predicted, digital health investment reached new heights in 2017 with $11.5B in funding across 794 deals. Looking beyond the
numbers provides insight into a sector transitioning to a more mature phase. Deal activity at the early stage has fueled a startup
wave and a maturing market with more later-stage opportunities is attracting new investment globally. 2018 is poised to be a
dynamic year in terms of digital health funding activity, M&A and breakout successes, and experimentation paving the way for
new advancements.
2018 StartUp Health Insights Global Digital Health Funding Report 2018 MidyearStartUp Health
The first half of 2018 has brought an increase in deal volume and a total of $6.1B invested in digital health companies across the globe - showing a heightened confidence in the sector.
mHealth Israel_PwC Top Health Industry Issues of 2020Levi Shapiro
Review of 2020's top healthcare issues, by Ben Isgur, Head, PwC Health Research Institute:
1) A looming tsunami of high prices
2) Regulations trumps policy
3) Consumers inch closer to DIY healthcare
4) A whole new you- deals as makeovers
5) Equity and inclusion, not just diversity, as a business imperative
6) US health organizations are seeking opportunities overseas and through innovation. Beware of the tax risks
7) Fast- forwarding from data to decisions
Healthcare executives maintain a relatively positive outlook for the upcoming year. The majority remain optimistic, expecting similar growth to last year in revenue, prices, volume and capital spending. Many other non-financial trends within the industry are also seen as having a beneficial impact on consumers and the quality of care being delivered.
For one, trends around Mergers & Acquisitions (M&A) are increasing from last year, with a general optimism about the impact, especially on the industry side, for efficiency and revenue. About three-quarters of executives also believe that increased M&A may result in a greater focus on care (over business administration.)
Second, most executives anticipate a continued--and increasing--reliance on technology that should improve quality and reduce costs. But with higher stakes, the challenge will be how to seamlessly incorporate technology industry-wide without compromising security.
Despite the optimistic tone, however, healthcare costs continue to be an untenable uphill battle for consumers, with no improvement over last year. Executives perceive that these overwhelming costs are damaging care and that many consumers may be sacrificing care to save money. Many executives claim they are working to figure out ways to alleviate this problem. In addition, executives are more open to government involvement with regulating the industry, but there is very little consensus on how to measure success and utilize outcomes.
The COVID-19 crisis is threatening the lives and well-being of the global community. Health, political, societal, and business leaders must drive an integrated response to navigate, manage, and lead through it.
Impact of covid 19 on indian stock market with reference to Pharmaceutical, I...BhaumikMajithia
The report talks about how the indian stock market is affected from COVID-19 and also for reference we have used market price trends of 9 companies like Infosys, TCS, Hero Motocorp, Tata Motors, HCL, Maruti Suzuki, Sn pharma, Panacea Biotec and Zydus Wellness.
PwC’s new Golden Age Index – how well are countries harnessing the power of o...PwC
One of the key megatrends affecting the UK and most other developed countries is an ageing population. Harnessing the potential of older workers will therefore become an increasingly important source of competitive advantage for both nations and businesses.
To explore how the UK compares with other OECD economies in this regard, PwC has developed a new ‘Golden Age index’ comparing how well they are utilising workers aged 55 and over. The index includes relative employment, earnings and training rates for older workers for 34 OECD countries over the period since 2003.
State Of Healthcare Q2’21 Report: Investment & Sector Trends To Watch. Contents include Summary, Market Drivers, Investment Trends, Sector Highlights (AI, Health IT, Omics, telehealth, digital therapeutics, mental health, medical devices, digital health, etc). Global healthcare investment rose for the seventh consecutive quarter. European investment nearly doubled. A flood of new entrants pushed early-stage deal share
above 50%. M&A activity persisted. The top healthcare deals in the quarter (by deal size) went to companies working in life sciences. The SPAC frenzy continued within digital health. Eleven healthcare startups joined the unicorn club during
Q2’21 (valued in aggregate at $27B).
FINN Partners Global State of Digital Health Q3 2022Levi Shapiro
Global State of Digital Health, Q3 2022, prepared by Finn Partners and Galen Growth.
While most analyses suggest digital health investment is declining, that’s a superficial assessment. Last year – when patients were separated from the health professional community – investors from all sectors jumped in with investments to learn and save their business models. That investment surge was from exuberance. Now, the monies being deployed are strategic. More important, 2022 numbers are far higher than the pre-pandemic equity invested in 2019.
While more than 60% of the total venture funding value comes from North America, on a regional level, the Middle East (primarily Israel by 92% and the United Arab Emirates) set record highs in venture funding in Q2 2022. Europe maintains momentum throughout 2022 and has not experienced the quarter-on-quarter decrease in venture funding seen in North America. Regions with increased investment correspond to established regulatory, public health and payer systems that prioritize digital health use. Israel – and Israeli-based entrepreneurs – need to keep their profiles high.
Every quarter, Health 2.0 releases a summary set of data that explains where industry funding is going, which product segments are growing fastest, and where new company formation is happening. Health 2.0’s precision and clarity when it comes to market segmentation and product information make this quarterly release the cream of the freebie crop.
StartUp Health Insights Report - Digital Health Funding Data 2015 Q1StartUp Health
What happened in the beginning of 2015?
~Investors backed later stage digital health companies as the market matures
~Funding in breakout metro areas including San Diego and Denver grew significantly, but the Bay Area continues to lead with $390M
~Wellness startups increased in popularity to become the second most active subsector
~Close to 41% of all digital health funding YTD has 50+ relevance
Mercer Capital's Value Focus: Medical Device Manufacturers | Q4 2015 | Five T...Mercer Capital
Mercer Capital provides medical device manufacturers, related start-up enterprises, and private equity funds with valuation services, including purchase price allocation, 409a compliance, goodwill impairment testing, and other transaction and valuation advisory services.
At mid-year, U.S. healthcare venture fundraising
reached $4.5 billion, and is on pace to closely match
the 2017 record of $9.1 billion. Great trends/insights from SVB.
Trends in Healthcare Investments and Exits 2018 - Mid-Year ReportSilicon Valley Bank
In our mid-year Healthcare Investments and Exits report, we analyzed the fundraising, investment, M&A and IPO activity of private, venture-backed biopharma, medical device and diagnostic/tools companies.
John Babitt, Partner, Life Sciences, Transaction Advisory Services, Ernst & Young LLP, presented at MEDTECH 2014 on The State of Change: A Look at the Evolving Healthcare Landscape and the Effect on Life Science Organizations Today and Tomorrow.
Health Technology startup quarterly highlights. Includes a sector summary, recent events, and a deep dive into Digital Medical Devices. Contact info@venturescanner.com or visit www.venturescanner.com to learn more about our research platform for technology startups!
Start up health Insights Digital Health Funding Rankings 2016 Mid Year RankingDexter Wee
Source : Startuphealth.com
Digital Health Funding Ranking 2016 Mid Year Report
Seed and Series A deals are 65 % of the funding rounds.
7600 startups around the world.
StartUp Health Insights 2016 Midyear ReportStartUp Health
The digital health market broke historic records for midyear funding as investment reached $3.9B. Seed and Series A financing rounds are substantially equal in number, demonstrating a still thriving early-stage innovation landscape. Most funding dollars are being funneled to Series A rounds, creating opportunities for companies with validated solutions.
Every quarter, Health 2.0 releases a summary set of data that explains where industry funding is going, which product segments are growing fastest, and where new company formation is happening. Health 2.0’s precision and clarity when it comes to market segmentation and product information make this quarterly release the cream of the freebie crop.
StartUp Health Insights Digital Health Funding Rankings Q3 2015 ReportStartUp Health
Q3 2015 continues to demonstrate a trend towards digital health market maturity with an increase of investment dollars combined with larger, less frequent deals.
~ Benefits and insurance solutions remain at the top of the deals list for 2015, particularly as these businesses become more capital intensive. Genomics companies are also beginning to attract funding as the line between biotech and consumer health blurs.
~ While it’s no surprise that the Bay Area continues to bring in the most funding YTD, newer markets are also growing. With Chicago, Salt Lake City and South Florida each taking in over $125M, it’s clear that investment opportunities are everywhere.
~ Keeping with last year’s trend, seed and series A rounds comprise 64% of funding activity this quarter. Meanwhile, series B and C rounds are continuing to increase their share of the total 2015 deals, demonstrating the maturation of the market.
~ Investments relevant to the 50+ market have contributed to nearly half the funding in the last five years, with the number of deals as a percent of all digital health steadily increasing.
Digital Health Funding For The 50+ market - 2014 Q3 YTDSanjay Khurana
While investment in the 50+ market accounts for 44% ($2.2B) of the overall YTD investment in Digital Health
($5.0B), it is estimated that 50+ focused companies comprise only 12% ($269M) of that subset. For consumers
who spend $1.6 trillion on healthcare, this represents an unmet need for innovation and opportunity for growth.
Every quarter, Health 2.0 releases a summary set of data that explains where industry funding is going, which product segments are growing fastest, and where new company formation is happening. Health 2.0’s precision and clarity when it comes to market segmentation and product information make this quarterly release the cream of the freebie crop.
Improving profitability for small businessBen Wann
In this comprehensive presentation, we will explore strategies and practical tips for enhancing profitability in small businesses. Tailored to meet the unique challenges faced by small enterprises, this session covers various aspects that directly impact the bottom line. Attendees will learn how to optimize operational efficiency, manage expenses, and increase revenue through innovative marketing and customer engagement techniques.
"𝑩𝑬𝑮𝑼𝑵 𝑾𝑰𝑻𝑯 𝑻𝑱 𝑰𝑺 𝑯𝑨𝑳𝑭 𝑫𝑶𝑵𝑬"
𝐓𝐉 𝐂𝐨𝐦𝐬 (𝐓𝐉 𝐂𝐨𝐦𝐦𝐮𝐧𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬) is a professional event agency that includes experts in the event-organizing market in Vietnam, Korea, and ASEAN countries. We provide unlimited types of events from Music concerts, Fan meetings, and Culture festivals to Corporate events, Internal company events, Golf tournaments, MICE events, and Exhibitions.
𝐓𝐉 𝐂𝐨𝐦𝐬 provides unlimited package services including such as Event organizing, Event planning, Event production, Manpower, PR marketing, Design 2D/3D, VIP protocols, Interpreter agency, etc.
Sports events - Golf competitions/billiards competitions/company sports events: dynamic and challenging
⭐ 𝐅𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐬:
➢ 2024 BAEKHYUN [Lonsdaleite] IN HO CHI MINH
➢ SUPER JUNIOR-L.S.S. THE SHOW : Th3ee Guys in HO CHI MINH
➢FreenBecky 1st Fan Meeting in Vietnam
➢CHILDREN ART EXHIBITION 2024: BEYOND BARRIERS
➢ WOW K-Music Festival 2023
➢ Winner [CROSS] Tour in HCM
➢ Super Show 9 in HCM with Super Junior
➢ HCMC - Gyeongsangbuk-do Culture and Tourism Festival
➢ Korean Vietnam Partnership - Fair with LG
➢ Korean President visits Samsung Electronics R&D Center
➢ Vietnam Food Expo with Lotte Wellfood
"𝐄𝐯𝐞𝐫𝐲 𝐞𝐯𝐞𝐧𝐭 𝐢𝐬 𝐚 𝐬𝐭𝐨𝐫𝐲, 𝐚 𝐬𝐩𝐞𝐜𝐢𝐚𝐥 𝐣𝐨𝐮𝐫𝐧𝐞𝐲. 𝐖𝐞 𝐚𝐥𝐰𝐚𝐲𝐬 𝐛𝐞𝐥𝐢𝐞𝐯𝐞 𝐭𝐡𝐚𝐭 𝐬𝐡𝐨𝐫𝐭𝐥𝐲 𝐲𝐨𝐮 𝐰𝐢𝐥𝐥 𝐛𝐞 𝐚 𝐩𝐚𝐫𝐭 𝐨𝐟 𝐨𝐮𝐫 𝐬𝐭𝐨𝐫𝐢𝐞𝐬."
What is the TDS Return Filing Due Date for FY 2024-25.pdfseoforlegalpillers
It is crucial for the taxpayers to understand about the TDS Return Filing Due Date, so that they can fulfill your TDS obligations efficiently. Taxpayers can avoid penalties by sticking to the deadlines and by accurate filing of TDS. Timely filing of TDS will make sure about the availability of tax credits. You can also seek the professional guidance of experts like Legal Pillers for timely filing of the TDS Return.
Memorandum Of Association Constitution of Company.pptseri bangash
www.seribangash.com
A Memorandum of Association (MOA) is a legal document that outlines the fundamental principles and objectives upon which a company operates. It serves as the company's charter or constitution and defines the scope of its activities. Here's a detailed note on the MOA:
Contents of Memorandum of Association:
Name Clause: This clause states the name of the company, which should end with words like "Limited" or "Ltd." for a public limited company and "Private Limited" or "Pvt. Ltd." for a private limited company.
https://seribangash.com/article-of-association-is-legal-doc-of-company/
Registered Office Clause: It specifies the location where the company's registered office is situated. This office is where all official communications and notices are sent.
Objective Clause: This clause delineates the main objectives for which the company is formed. It's important to define these objectives clearly, as the company cannot undertake activities beyond those mentioned in this clause.
www.seribangash.com
Liability Clause: It outlines the extent of liability of the company's members. In the case of companies limited by shares, the liability of members is limited to the amount unpaid on their shares. For companies limited by guarantee, members' liability is limited to the amount they undertake to contribute if the company is wound up.
https://seribangash.com/promotors-is-person-conceived-formation-company/
Capital Clause: This clause specifies the authorized capital of the company, i.e., the maximum amount of share capital the company is authorized to issue. It also mentions the division of this capital into shares and their respective nominal value.
Association Clause: It simply states that the subscribers wish to form a company and agree to become members of it, in accordance with the terms of the MOA.
Importance of Memorandum of Association:
Legal Requirement: The MOA is a legal requirement for the formation of a company. It must be filed with the Registrar of Companies during the incorporation process.
Constitutional Document: It serves as the company's constitutional document, defining its scope, powers, and limitations.
Protection of Members: It protects the interests of the company's members by clearly defining the objectives and limiting their liability.
External Communication: It provides clarity to external parties, such as investors, creditors, and regulatory authorities, regarding the company's objectives and powers.
https://seribangash.com/difference-public-and-private-company-law/
Binding Authority: The company and its members are bound by the provisions of the MOA. Any action taken beyond its scope may be considered ultra vires (beyond the powers) of the company and therefore void.
Amendment of MOA:
While the MOA lays down the company's fundamental principles, it is not entirely immutable. It can be amended, but only under specific circumstances and in compliance with legal procedures. Amendments typically require shareholder
Cracking the Workplace Discipline Code Main.pptxWorkforce Group
Cultivating and maintaining discipline within teams is a critical differentiator for successful organisations.
Forward-thinking leaders and business managers understand the impact that discipline has on organisational success. A disciplined workforce operates with clarity, focus, and a shared understanding of expectations, ultimately driving better results, optimising productivity, and facilitating seamless collaboration.
Although discipline is not a one-size-fits-all approach, it can help create a work environment that encourages personal growth and accountability rather than solely relying on punitive measures.
In this deck, you will learn the significance of workplace discipline for organisational success. You’ll also learn
• Four (4) workplace discipline methods you should consider
• The best and most practical approach to implementing workplace discipline.
• Three (3) key tips to maintain a disciplined workplace.
RMD24 | Debunking the non-endemic revenue myth Marvin Vacquier Droop | First ...BBPMedia1
Marvin neemt je in deze presentatie mee in de voordelen van non-endemic advertising op retail media netwerken. Hij brengt ook de uitdagingen in beeld die de markt op dit moment heeft op het gebied van retail media voor niet-leveranciers.
Retail media wordt gezien als het nieuwe advertising-medium en ook mediabureaus richten massaal retail media-afdelingen op. Merken die niet in de betreffende winkel liggen staan ook nog niet in de rij om op de retail media netwerken te adverteren. Marvin belicht de uitdagingen die er zijn om echt aansluiting te vinden op die markt van non-endemic advertising.
Buy Verified PayPal Account | Buy Google 5 Star Reviewsusawebmarket
Buy Verified PayPal Account
Looking to buy verified PayPal accounts? Discover 7 expert tips for safely purchasing a verified PayPal account in 2024. Ensure security and reliability for your transactions.
PayPal Services Features-
🟢 Email Access
🟢 Bank Added
🟢 Card Verified
🟢 Full SSN Provided
🟢 Phone Number Access
🟢 Driving License Copy
🟢 Fasted Delivery
Client Satisfaction is Our First priority. Our services is very appropriate to buy. We assume that the first-rate way to purchase our offerings is to order on the website. If you have any worry in our cooperation usually You can order us on Skype or Telegram.
24/7 Hours Reply/Please Contact
usawebmarketEmail: support@usawebmarket.com
Skype: usawebmarket
Telegram: @usawebmarket
WhatsApp: +1(218) 203-5951
USA WEB MARKET is the Best Verified PayPal, Payoneer, Cash App, Skrill, Neteller, Stripe Account and SEO, SMM Service provider.100%Satisfection granted.100% replacement Granted.
The world of search engine optimization (SEO) is buzzing with discussions after Google confirmed that around 2,500 leaked internal documents related to its Search feature are indeed authentic. The revelation has sparked significant concerns within the SEO community. The leaked documents were initially reported by SEO experts Rand Fishkin and Mike King, igniting widespread analysis and discourse. For More Info:- https://news.arihantwebtech.com/search-disrupted-googles-leaked-documents-rock-the-seo-world/
Falcon stands out as a top-tier P2P Invoice Discounting platform in India, bridging esteemed blue-chip companies and eager investors. Our goal is to transform the investment landscape in India by establishing a comprehensive destination for borrowers and investors with diverse profiles and needs, all while minimizing risk. What sets Falcon apart is the elimination of intermediaries such as commercial banks and depository institutions, allowing investors to enjoy higher yields.
Explore our most comprehensive guide on lookback analysis at SafePaaS, covering access governance and how it can transform modern ERP audits. Browse now!
3.0 Project 2_ Developing My Brand Identity Kit.pptxtanyjahb
A personal brand exploration presentation summarizes an individual's unique qualities and goals, covering strengths, values, passions, and target audience. It helps individuals understand what makes them stand out, their desired image, and how they aim to achieve it.
What are the main advantages of using HR recruiter services.pdfHumanResourceDimensi1
HR recruiter services offer top talents to companies according to their specific needs. They handle all recruitment tasks from job posting to onboarding and help companies concentrate on their business growth. With their expertise and years of experience, they streamline the hiring process and save time and resources for the company.
RMD24 | Retail media: hoe zet je dit in als je geen AH of Unilever bent? Heid...BBPMedia1
Grote partijen zijn al een tijdje onderweg met retail media. Ondertussen worden in dit domein ook de kansen zichtbaar voor andere spelers in de markt. Maar met die kansen ontstaan ook vragen: Zelf retail media worden of erop adverteren? In welke fase van de funnel past het en hoe integreer je het in een mediaplan? Wat is nu precies het verschil met marketplaces en Programmatic ads? In dit half uur beslechten we de dilemma's en krijg je antwoorden op wanneer het voor jou tijd is om de volgende stap te zetten.
As a business owner in Delaware, staying on top of your tax obligations is paramount, especially with the annual deadline for Delaware Franchise Tax looming on March 1. One such obligation is the annual Delaware Franchise Tax, which serves as a crucial requirement for maintaining your company’s legal standing within the state. While the prospect of handling tax matters may seem daunting, rest assured that the process can be straightforward with the right guidance. In this comprehensive guide, we’ll walk you through the steps of filing your Delaware Franchise Tax and provide insights to help you navigate the process effectively.
Skye Residences | Extended Stay Residences Near Toronto Airportmarketingjdass
Experience unparalleled EXTENDED STAY and comfort at Skye Residences located just minutes from Toronto Airport. Discover sophisticated accommodations tailored for discerning travelers.
Website Link :
https://skyeresidences.com/
https://skyeresidences.com/about-us/
https://skyeresidences.com/gallery/
https://skyeresidences.com/rooms/
https://skyeresidences.com/near-by-attractions/
https://skyeresidences.com/commute/
https://skyeresidences.com/contact/
https://skyeresidences.com/queen-suite-with-sofa-bed/
https://skyeresidences.com/queen-suite-with-sofa-bed-and-balcony/
https://skyeresidences.com/queen-suite-with-sofa-bed-accessible/
https://skyeresidences.com/2-bedroom-deluxe-queen-suite-with-sofa-bed/
https://skyeresidences.com/2-bedroom-deluxe-king-queen-suite-with-sofa-bed/
https://skyeresidences.com/2-bedroom-deluxe-queen-suite-with-sofa-bed-accessible/
#Skye Residences Etobicoke, #Skye Residences Near Toronto Airport, #Skye Residences Toronto, #Skye Hotel Toronto, #Skye Hotel Near Toronto Airport, #Hotel Near Toronto Airport, #Near Toronto Airport Accommodation, #Suites Near Toronto Airport, #Etobicoke Suites Near Airport, #Hotel Near Toronto Pearson International Airport, #Toronto Airport Suite Rentals, #Pearson Airport Hotel Suites
2. 5
Contents
1 0 Q1’20 Global Healthcare Investment
Trends
7 3 Appendix:
Most Active VC Investors Q1'20
Methodology
3 6 Q1'20 Healthcare Industry Highlights
Q1’20 Spotlight: Covid-19
AI
Telehealth
Medical Devices
Digital Health In China
Women’s Health
Mental Health
Regenerative Medicine2 0 Q1’20 Global Digital Health
Investment Trends
3 0
3. 1
Summary of findings
Funding to North American companies reached an all-time high: North
American healthcare companies raised $10.3B in Q1’20, the highest quarterly
level on record and a 35% increase from Q4’19. This was driven by a record-high
number of mega-rounds (25).
Globally, there are 42 healthcare unicorns worth a combined $101.5B: The
cohort’s total valuation continued to grow with the addition of Insightec ($1.3B
valuation) and Alto Pharmacy ($1B).
G L O B A L D I G I T A L H E A L T H I N V E S T M E N T
Digital health deals and dollars slid in Q1’20: Global digital health funding
came in at $4.5B for Q1’20, down 8% from Q4’19. Deals also declined quarter-
over-quarter, coming in at 408, down 4% from Q4’19. Declines in deal activity
were led by China.
In the US, New York regained the #2 spot for digital health deals: After falling
behind Massachusetts in Q4’19, New York state regained the #2 spot with 32
digital health deals in Q1’20. New York metro deals surpassed Silicon Valley
deals by 48% in the quarter, though at the state level California continues to
lead with 74 deals.
(Summary continued on the next page)
C O V I D - 1 9
Covid-19 had a material impact on China’s deal activity: Between Q4’19 and
Q1’20, China’s healthcare deals dropped by nearly 40% to 100, the lowest level
seen since Q2’17. The decline was particularly steep in the digital health space,
where deals and dollars both dropped by more than 50% since Q4’19.
Covid-19 prompted swift responses from government, industry, and academia:
Healthcare stakeholders have responded to the crisis by providing new and
expanded product offerings, adjusting regulatory policy, and forging
collaborative partnerships. Going forward, tech giants will likely play a larger
role in strategy and implementation of future public health responses.
Covid-19 put on a spotlight on telehealth: Amid the Covid-19 pandemic, both
telehealth deals and news mentions doubled from Q4’19. Several payers and
providers expanded access to virtual care, and telehealth companies from
around the globe reported significant upticks in visit volume.
G L O B A L H E A L T H C A R E I N V E S T M E N T
Global healthcare investment: Healthcare startups closed 1,156 funding rounds
in Q1’20, the lowest level since Q4’18. Despite the slide, equity funding
continued to rise, surpassing $14.6B. March was the strongest month in the
quarter with $5.7B raised.
Note: This report focuses on equity rounds to private healthcare companies. All data is sourced from CB Insights.
4. 7
Summary of findings
Telehealth and diagnostics remained popular segments in the women’s health
space. After 3 consecutive quarterly declines, women’s health funding
increased, rising 150% from Q4’19 levels. Q1'20 deals demonstrated a
continued interest in women’s telehealth providers and improved prenatal
diagnostic solutions.
Mental health funding reached a record-high. Mental health startups raised a
record $576M – surpassing the prior quarterly record by over 60% — across 44
deals in Q1’20. Employer-focused startups took center stage, closing several
$20M+ rounds.
Cell therapies drove mega-rounds and exits in regenerative medicine in Q1’20.
Deals to 3 cell therapy startups ranked among the top 10 healthcare deals
globally for the quarter. Within the regenerative medicine space, cell-based
immuno-oncology startups closed some of the largest rounds and were a focal
point of M&A and IPO activity.
H E A L T H C A R E I N D U S T R Y T R E N D S
Healthcare AI deals and dollars rose but remained below Q3’19 peak.
Healthcare AI startups raised $984M in equity funding across 80 deals in Q1’20.
Funding rose by 37% from Q4’19 but stood well below Q3’19’s peak of $1.6B.
Deals rose by 3% from Q4’19 but were still down 34% compared to Q3’19’s peak
of 122 deals.
Telehealth deals reached a record high in Q1'20. During the quarter, telehealth
startups closed 103 deals, double the amount seen in Q4’19 and the highest
level on record.
Infectious disease and life-support devices dominated the medical devices
space. Infectious disease diagnostics startups were a focal point of Q1’20
funding. Karius’ $165M Series B round ranked among the top 10 healthcare
deals globally. Mega-rounds were common in the life-support segment as well:
Element Science and Outset Medical raised $145.6M and $125M, respectively.
Deals and dollars to China-based digital health companies declined. Deals
declined by 51% quarter-over-quarter to 27 in Q1’20, the lowest level since
Q2’17. At $318M, Q1’20 funding was at its lowest since Q3’17.
Note: This report focuses on equity rounds to private healthcare companies. All data is sourced from CB Insights.
5. The image part with relationship ID rId2 was not found in the file.
#AhaCBI
Q1’20 Global
Healthcare
Investment
Trends
6. 10
Funding grew 4% in Q1’20 while deals fell 6% since Q4’19
Quarterly global healthcare funding and deal count, Q2'17 – Q1'20
G L O B A L H E A L T H C A R E I N V E S T M E N T T R E N D S
Amount ($M) Deal Count
$9,534 $9,547 $10,470 $13,385 $15,513 $16,562 $12,120 $13,521 $13,944 $13,095 $14,090 $14,624
1,059
1,010
1,107
1,150
1,318
1,268
1,125
1,252
1,304
1,266
1,228
1,156
500
600
700
800
900
1,000
1,100
1,200
1,300
1,400
$-
$2,000
$4,000
$6,000
$8,000
$10,000
$12,000
$14,000
$16,000
$18,000
Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20
7. 11
Mid-stage deal share reached a new high in Q1’20
Percent share of global healthcare deals, Q2’17 – Q1’20
Note: “Early-stage” includes convertible note, angel, seed, and Series A rounds. “Mid-stage” includes Series B and Series C rounds. “Late-stage” includes Series D,
Series E+, growth equity, and private equity rounds. “Other” includes unattributed and corporate minority rounds.
G L O B A L H E A L T H C A R E I N V E S T M E N T T R E N D S
Other
Late-stage
Early-stage
Mid-stage
52% 51% 50% 52% 52% 50% 46% 51% 48%
53% 51%
46%
14% 14% 13% 13% 16%
14%
15%
14% 15%
15% 16%
18%
6% 7% 7%
7% 7%
7%
7%
7% 8%
6% 7%
6%
27% 28% 30% 27% 25% 29% 31% 29% 28% 27% 26% 30%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20
8. 12
North American funding grew 35% quarter-over-quarter
Global healthcare funding ($M) by continent, Q2’17 – Q1'20
Other category includes Africa, South America, and Australia.
G L O B A L H E A L T H C A R E I N V E S T M E N T T R E N D S
Other
Europe
North America
Asia
$6,567
$7,246 $6,932
$8,508
$9,335
$10,303
$8,939 $8,746 $8,623 $7,990 $7,658
$10,306
$932
$2,386 $2,472
$3,468
$4,229
$4,733
$1,893
$2,985
$3,872
$2,152
$4,171
$2,404
$1,924
$791 $1,509
$1,363
$1,879
$1,484
$1,244
$1,728
$1,289
$2,899
$2,089
$1,463
$125
$48
$20
$45
$70
$42
$45
$62
$160
$53
$172
$450
Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20
9. 13
The US saw a record number of mega-rounds in Q1’20
Quarterly healthcare mega-round deal count by country, Q2'17 – Q1'20
Includes countries with 5+ healthcare mega-rounds since Q2’17.
G L O B A L H E A L T H C A R E I N V E S T M E N T T R E N D S
10
8
10
13
17
20
15 14 14 14
7
25
2
4
4
6
12
4 6
8
3
8
3
1
1
3
2
3
1
2
1
2
1
1
2
1
2
Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20
United States China United Kingdom India Switzerland
10. 14
China saw a dramatic drop in deals in Q1’20
Quarterly healthcare deals by country, Q2'17 – Q1'20
Includes countries with 100+ healthcare deals since Q2’17.
G L O B A L H E A L T H C A R E I N V E S T M E N T T R E N D S
5 Deals 725 Deals
11. 15
Company Deal Date //
Amount Raised
Total Disclosed
Funding
Select Investors Description
Mar ’20 //
$493M
$851M Undisclosed Investors Lyell Immunopharma is a cellular therapy
company dedicated to mastering immune cell
functionality.
Mar’20 //
$350M
$350M Webster Equity Partners RCA is a management service organization
(MSO) focused on retina specialist practices.
Jan’20 //
$250M
$351.6M Greenoaks Capital Management, Jackson Square
Ventures, Olive Tree Capital, SoftBank Group, Zola
Global Investors
Alto Pharmacy offers free, same-day
prescription delivery. It aims to find patients
low prices and provides 24/7 pharmacist
support.
Jan’20 //
$200M
$200M Andreessen Horowitz, Arboretum Ventures, ARCH
Venture Partners, Casdin Capital, Google Ventures,
Nextech Invest, Section 32
EQRx is a biotechnology company focused on
re-engineering the process from drug discovery
to patient delivery with the goal of offering a
market-based solution for the rising cost of
medicines.
Mar’20 //
$170M
$320M EcoR1 Capital, EDBI, F2 Ventures, Invus Group, MPM
Capital, Redmile Group, Samsara BioCapital, Surveyor
Capital, Vertex Ventures
ElevateBio creates and operates a portfolio of
cell and gene therapy companies to develop,
manufacture, and commercialize medicines.
Top 10 global healthcare deals in Q1'20
12. 1
Company Deal Date //
Amount Raised
Total Disclosed
Funding
Select Investors Description
Feb’20 //
$165M
$240M General Catalyst, HBM Healthcare Investments, Khosla
Ventures, Lightspeed Venture Partners, SoftBank
Group
Karius is a life sciences company focused on
treating infectious diseases by sequencing
microbial cell-free DNA directly from blood.
Feb’20 //
$157M
$157M Inner Mongolia Junzheng Energy Hebei Daan Pharmaceutical Co. Ltd.
manufactures immunoglobulin products for use
in medicine.
Jan’20 //
$155M
$250.6M Accel, Creandum, Index Ventures, Ontario Teachers'
Pension Plan
KRY is a CE-certified, app-based service for
meeting doctors through video meetings in
Sweden.
Mar’20 //
$150M
$150M Hudson Bay Capital Management, Johnson & Johnson
Innovation, Lilly Asia Ventures, RA Capital
Management, Vivo Capital
Legend Biotech is a multinational
biopharmaceutical company that focuses on
discovering and developing cutting-edge cell-
based therapies.
Jan’20 //
$150M
$170M AllianceBernstein, Declaration Partners, Maverick
Ventures, SymphonyAI Group
Concerto HealthAI specializes in integrated clinical
RWD and AI solutions.
Top 10 global healthcare deals in Q1’20
13. 3
SWITZERLAND
EUROPE
$2.0B
$1.0B
42 healthcare unicorns valued at $101.5B
Global healthcare companies with a private market valuation of $1B+ (4/8/2020)
UNITED KINGDOM
MIDDLE EAST
$1.0B
ISRAEL
$1.7B
$2.1B
GERMANY
$1.7B
CHINA
ASIA
$5.5B
$5.0B
$2.4B
FRANCE
$1.1B $3.5B
$1.6B
$1.0B
$1.0B
$1.0B
$1.0B
$2.0B
$1.0B
NORTH AMERICA
UNITED STATES
$12B Valuation
$3.2B
$1.0B
$1.1B
$2.5B
$1.8B
$1.3B
$5.5B
$4.2B
$1.2B
$9.0B
$5.0B
$2.8B
$3.2B
$1.8B
$1.5B
$1.3B
$1.2B
$1.0B
$1.0B
S. KOREA
$1.0B
$1.3B
$1.0B
$1.0B
14. The image part with relationship ID rId2 was not found in the file.
#AhaCBI
Q1’20 Global
Digital Health
Investment
Trends
15. 20
Deals and dollars dropped 8% and 4% quarter-over-quarter
Global digital health funding and deal count, Q2'17 – Q1'20
G L O B A L D I G I T A L H E A L T H I N V E S T M E N T T R E N D S
Amount ($M) Deal Count
$3,154 $3,398 $2,462 $3,845 $4,455 $5,773 $3,601 $3,472 $5,529 $3,619 $4,736 $4,542
389 384
417
405
514
440
363
421
434
416
445
408
-
50
100
150
200
250
300
350
400
450
500
550
$-
$200
$400
$600
$800
$1,000
$1,200
$1,400
$1,600
$1,800
$2,000
$2,200
$2,400
$2,600
$2,800
$3,000
$3,200
$3,400
$3,600
$3,800
$4,000
$4,200
$4,400
$4,600
$4,800
$5,000
$5,200
$5,400
$5,600
$5,800
$6,000
$6,200
Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20
16. 21
Mid-stage deal share reached a new high at 23%
Percent share of global digital health deals, Q2’17 – Q1’20
Note: “Early-stage” includes convertible note, angel, seed, and Series A rounds. “Mid-stage” includes Series B and Series C rounds. “Late-stage” includes Series D,
Series E+, growth equity, and private equity rounds. “Other” includes unattributed and corporate minority rounds.
G L O B A L D I G I T A L H E A L T H I N V E S T M E N T T R E N D S
Other
Late-stage
Early-stage
Mid-stage
64% 66%
61% 60%
65%
59% 61% 63% 60%
66%
59%
53%
14% 11%
16% 15%
15%
15%
16% 15% 19%
17%
19%
23%
4% 3% 4% 6%
5%
6%
4%
5% 7% 2%
7%
5%
18% 20% 19% 19% 15%
20% 19% 16% 14% 15% 15% 19%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20
17. 22
‘Other’ funding surpassed $100M for the first time
Global digital health funding ($M) by continent, quarterly, Q2’17 – Q1’20
Other category includes Africa, South America, and Australia.
G L O B A L D I G I T A L H E A L T H I N V E S T M E N T T R E N D S
Other
Europe
North America
Asia
$2,851
$1,775 $1,945
$2,502 $2,496
$3,789
$2,875
$1,842
$3,028
$2,001
$3,047 $3,234
$211
$396
$695
$946
$1,396
$1,377
$386
$987
$2,080
$719
$1,167 $706
$284
$249
$398
$395
$516
$591
$313
$629
$401
$876
$487
$487
$53
$42
$17
$1
$46
$16
$27
$14
$20
$23
$35
$115
Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20
18. 23
Q1’20 saw 10 digital health mega-rounds, led by US
Digital health mega-round deal count by country, Q2'17 – Q1'20
Includes countries with 1+ digital health mega-rounds since Q2’17
G L O B A L D I G I T A L H E A L T H I N V E S T M E N T T R E N D S
5
3 3 3
4
7
6
1
3
4
2
71 1 1
2
4
1
2
4
1
3
1
1
1
1
1
1
1
1
1
1
Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20
United States China United Kingdom India Sweden France
19. 24
Deals to China fell to lowest level since Q2’17
Digital health deals by country, Q2'17 – Q1'20
Includes countries with 20+ digital health deals since Q2’17.
G L O B A L D I G I T A L H E A L T H I N V E S T M E N T T R E N D S
5 Deals 267 Deals
20. 25
NY regained the #2 spot for deals among US states
Digital health deals by US state, quarterly, Q2'17 – Q1'20
Includes US states with 200+ digital health deals since Q2’17.
T H E U N I T E D S T A T E S O F D I G I T A L H E A L T H
69
73
64 64
92
72
48 50
69
73
67
74
24
19
16
26
43
23
19
29 30
33
18
32
18 18
12
21 20
17
21 20 21 21 19
28
Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20
California New York Massachusetts
21. 26
NY Metro deals surpassed Silicon Valley deals by 48%
Top 4 metro areas for digital health deals, Q2'17 – Q1'20
T H E U N I T E D S T A T E S O F D I G I T A L H E A L T H
-
5
10
15
20
25
30
35
40
45
Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20
Numberofdigitalhealthdeals
Silicon Valley New York Metro Boston Metro Los Angeles Metro
22. 27
Company Deal Date //
Amount Raised
Total Disclosed
Funding
Select Investors Description
Feb’20 //
$165M
$240M General Catalyst, HBM Healthcare Investments, Khosla
Ventures, Lightspeed Venture Partners, SoftBank
Group
Karius is a life sciences company focused on
treating infectious diseases by sequencing
microbial cell-free DNA directly from blood.
Jan’20 //
$155M
$250.6M Accel, Creandum, Index Ventures, Ontario Teachers'
Pension Plan
KRY is a CE-certified, app-based service for
meeting doctors through video meetings in
Sweden.
Jan’20 //
$150M
$170M AllianceBernstein, Declaration Partners, Maverick
Ventures, SymphonyAI Group
Concerto HealthAI specializes in integrated clinical
RWD and AI solutions.
Jan’20 //
$144M
$318.7M Bojiang Capital, CEC Data Capital, CMB International
Capital, LB Investment, Oriental Patron Financial
Group, Samsung Electronics, SIG Asia Investments,
Tasly Capital
Zhangshang Tangyi is a mobile diabetes
management app that allows patients to record
their own health data and receive medical
advice.
Mar’20 //
$135M
$375M Durable Capital Partners, Fidelity Investments, T. Rowe
Price
Alignment Healthcare partners with providers,
health plans, and hospitals to create continuous
care programs.
Top 10 global digital health deals in Q1'20
23. 28
Company Deal Date //
Amount Raised
Total Disclosed
Funding
Select Investors Description
Feb’20 //
$126.4M
$349.7M .406 Ventures, Cox Enterprises, F-Prime Capital, Flare
Capital Partners, Khosla Ventures, Polaris Partners,
Premji Invest, Temasek
Iora Health is a value-based, tech-enabled primary
care group that takes on financial and quality risks
for patients in Medicare Advantage and other
insurance programs (e.g. employers).
Mar’20 //
$112.0M
$243.0M Bill Gates, Euclidean Capital, Greenspring Associates,
Illumina Ventures, Lux Capital, Polaris Partners, Two
Sigma Ventures
Kallyope integrates technologies in sequencing,
computational biology, neural imaging, and
genetics to develop therapeutics targeting the
gut-brain axis.
Mar’20 //
$110.0M
$409.4M Accel, Ascent Capital, Chiratae Ventures, GableHorn
Investments, Temasek
CureFit offers products for preventive and
curative healthcare, combining engagement,
coaching, and delivery through a mix of online
and offline channels.
Mar’20 //
$100.0M
$620.0M Baillie Gifford & Co., Franklin Templeton, New
Enterprise Associates, Novo Holdings, T. Rowe Price
Tempus’s genomic sequencing services and its
analytical machine learning platform aim to
improve personalized cancer care.
Feb’20 //
$100.0M
$137.8M Bain Capital Ventures, Casdin Capital, Define Ventures,
Google Ventures
Verana Health assembles clinical databases in
medicine to empower physicians and accelerate
research for patients.
Top 10 global digital health deals in Q1'20
24. The image part with relationship ID rId2 was not found in the file.
#AhaCBI
Q1’20
Spotlight:
Covid-19
25. 33
Tech giants join forces on surveillance & supercomputing
The New York Times
C O V I D - 1 9
Apple and Google are partnering to develop and deploy an automatic,
anonymous Bluetooth-based contact tracing technology for Covid-19.
1 2
Amazon, Google, and Microsoft joined a consortium spearheaded by the White House Office of Science and
Technology Policy, the US Department of Energy, and IBM called The Covid-19 High Performance Computing
(HPC) Consortium.
Together, members will provide bioinformatics, epidemiology, and molecular biology researchers with
computing power to execute computational research programs on Covid-19.
T A K E A W A Y : It’s clear from these partnerships that key healthcare stakeholders benefit from tech giants’ data and computing capabilities. Big tech
players also have an advantage by offering solutions that can be widely disseminated and scaled up in times of crisis. In the future, this could impact how
local, state, and federal public health responses are orchestrated, with tech incumbents playing a large role in strategy and implementation.
26. The image part with relationship ID rId2 was not found in the file.
#AhaCBI
Q1’20
Healthcare
Industry
Highlights
27. 36
REGENERATIVE
MEDICINE
WOMEN’S
HEALTH
AI
MEDICAL
DEVICES
MENTAL
HEALTH
Companies selling AI SaaS to
healthcare clients or using AI to
develop products for the
healthcare market
Companies developing medical
devices that aid in the diagnosis, cure,
mitigation, treatment, monitoring, or
prevention of disease
Startups focused specifically on
providing healthcare products and
services to women
China-based healthcare startups
using digital technology as a key
differentiator over their
competition
Startups using technology to remotely
deliver clinical health services to
patients
Companies applying technology to
problems of emotional, psychological,
and social well-being
Companies involved in the R&D
or commercialization of gene
therapies, cell therapies, and
bio-engineered tissues
GLOBAL HEALTHCARE REPORT Q1'20
TELEHEALTH
DIGITAL
HEALTH
IN CHINA
28. 37
GLOBAL HEALTHCARE REPORT Q1'20
WOMEN’S
HEALTH
AI
MEDICAL
DEVICES
MENTAL
HEALTH
TELEHEALTH
DIGITAL
HEALTH
IN CHINA
REGENERATIVE
MEDICINE
HEALTHCARE Q1 2020
29. 38
$306 $598 $517 $745 $859 $762 $573 $619 $1,058 $1,640 $719 $984
45
81
59
64
92
67
58
91
85
122
78 80
-
20
40
60
80
100
120
140
$-
$200
$400
$600
$800
$1,000
$1,200
$1,400
$1,600
$1,800
Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20
Funding rose QoQ but remains below Q3’19 peak
H E A L T H C A R E A I D E A L S A N D D O L L A R S
Healthcare AI funding and deal count, Q2’17 – Q1’20
Amount ($M) Deal Count
30. 39
Company Deal Date //
Amount Raised
Total Disclosed
Funding
Select Investors Description
Top rounds to healthcare AI startups in Q1’20
H I G H L I G H T # 1 : I N F E C T I O U S D I S E A S E S T A R T U P S L E A D T O P D E A L S O F 2 0 2 0
Jan’20 //
$150.0M
Feb’20 //
$165.0M
Jan’20 //
$60.0M
Mar’20 //
$100.0M
Mar’20 //
$51.0M
$170.0M
$240.0M
$80.6M
$620.0M
$127.3M
AllianceBernstein, Declaration Partners, Maverick
Ventures, Symphony Technology Group
General Catalyst, Khosla Ventures, Lightspeed
Venture Partners, SoftBank Group, Tencent
Holdings
Matrix Capital Management, Matrix Partners,
Mayo Clinic Ventures, NTT Venture Capital
Lightbank, New Enterprise Associates, Novo
Holdings, Revolution Growth, T. Rowe Price
14W, Anthem, Bessemer Venture Partners,
BoxGroup, Comcast Ventures, Mangrove
Capital Partners, Max Ventures
Concerto is an oncology startup using AI to
support clinical development and match patients
to treatments.
Karius is an infectious disease testing company
using machine learning to analyze pathogen DNA
and identify the cause of disease.
Medical research company using neural networks
to gather patient notes, scientific literature, and
medical images for a biomedical database.
Tempus focuses on cancer treatment, using AI to
identify therapeutic options based on patient
clinical and molecular data.
Workflow automation startup using RPAs,
computer vision, and machine learning to
automate administrative workflows.
31. 40
H I G H L I G H T # 2 : K A R I U S C L O S E D T H E L A R G E S T A I H E A L T H C A R E D E A L O F Q 1 ’ 2 0
Total Funding
$240M
Valuation
$700M
Similar Companies:
$239.1M $29M $9.6M
Karius develops liquid biopsy tests for infectious
disease diagnosis. Its approach combines
machine learning algorithms with microbial cell-
free DNA sequencing.
Series BLatest Round:
$165MAmount:
General Catalyst, Khosla
Ventures, Lightspeed Venture
Partners, SoftBank Group
Select Round
Investors:
32. 42
GLOBAL HEALTHCARE REPORT Q1'20
WOMEN’S
HEALTH
AI
MEDICAL
DEVICES
MENTAL
HEALTH
TELEHEALTH
DIGITAL
HEALTH
IN CHINA
REGENERATIVE
MEDICINE
HEALTHCARE Q1 2020
33. 43
Deals doubled from Q4’19, reaching record high
T E L E H E A L T H D E A L S A N D D O L L A R S
Telehealth funding and deal count, Q2’17 – Q1’20
$470 $329 $293 $1,017 $1,340 $1,900 $731 $945 $1,014 $1,210 $418 $1,584
65
51
57
65
83
64
45
63
70
76
51
103
-
20
40
60
80
100
120
$-
$200
$400
$600
$800
$1,000
$1,200
$1,400
$1,600
$1,800
$2,000
Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20
Amount ($M) Deal Count
34. 44
Q1’20 telehealth mentions doubled from Q4’19 levels
H I G H L I G H T # 1 : C O V I D - 1 9 P A N D E M I C P U T S A S P O T L I G H T O N T E L E H E A L T H
Monthly news mentions, April ’15 – March ’20
News mentions
600
500
400
300
200
100
0
2016 2017 2018 2019 2020
35. 45
H I G H L I G H T # 2 : T E L E P H A R M A C Y S T A R T U P A L T O C L O S E D A $ 2 5 0 M M E G A - R O U N D
Total Funding
$351.6M
Valuation
$1.0B
Similar Companies
$270.0M $170.7M
Acquired by
Amazon in 2018
Alto Pharmacy provides free same-day
delivery 7 days a week for prescriptions. It
also offers in-app and phone support, as well
as coordination with doctors and insurance
companies.
Series D (1/30/2020)Latest Round:
$250MAmount:
SoftBank GroupLead Investor:
36. 46
Teletherapy services continue to broaden
H I G H L I G H T # 3 : T E L E H E A L T H C A T E R S T O F U L L M I N D A N D B O D Y C A R E
M E N T A L H E A L T H
Series C (3/11/2020)
$75M
Latest Round:
Amount:
Lyra’s platform connects
employees to therapists,
mental health coaches, and
personalized digital therapy
programs.
About:
B E H A V I O R A L H E A L T H
Unattributed (2/19/2020)
$2.5M
Latest Round:
Amount:
Halcyon Health is a substance
use disorder treatment
program focused on long-term
care.
About:
P H Y S I C A L H E A L T H
Series C (2/4/2020)
$75M
Latest Round:
Amount:
Hinge Health’s digital care
program combines sensor-
guided exercise therapy with
health coaching to enable at-
home physical therapy or
rehabilitation.
About:
37. 47
GLOBAL HEALTHCARE REPORT Q1'20
WOMEN’S
HEALTH
AI
MEDICAL
DEVICES
MENTAL
HEALTH
TELEHEALTH
DIGITAL
HEALTH
IN CHINA
REGENERATIVE
MEDICINE
HEALTHCARE Q1 2020
38. 48
Deals dropped 15% from Q4’19, reaching recent low
M E D I C A L D E V I C E D E A L S A N D D O L L A R S
Medical device funding and deal count, Q2’17 – Q1’20
$3,136 $3,332 $2,676 $2,946 $3,129 $3,423 $2,513 $3,357 $3,100 $2,707 $2,694 $2,932
350
369
346 345
380
362
307
334
349 357
330
282
-
50
100
150
200
250
300
350
400
$-
$500
$1,000
$1,500
$2,000
$2,500
$3,000
$3,500
$4,000
Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20
Amount ($M) Deal Count
39. 49
H I G H L I G H T # 1 : W E A R A B L E D E F I B R I L L A T O R M A K E R R A I S E S M E G A - R O U N D
Element Science uses machine learning to
design wearable medical devices.
Its main product is a wearable defibrillator to
defend against Sudden Cardiac Death (SCD),
which claims 325,000 lives a year in the US.
Element plans to use the $145.6M from its
Series C financing round to fund additional
clinical trials and initial commercialization
efforts for its SCD device.
Total Funding
$192.6M
Valuation
Not disclosed
Select
Series C
Investors
Series C (3/3/2020)Latest Round:
$145.6MAmount:
40. 50
Covid-19 highlighted the need for improved ID diagnostics
H I G H L I G H T # 2 : I M P R O V I N G I N F E C T I O U S D I S E A S E ( I D ) D I A G N O S T I C S
K A R I U S
Series B (2/24/2020)
$165M
Latest Round:
Amount:
Karius is a life sciences
company focused on treating
infectious diseases by
combining AI with sequencing of
microbial cell-free DNA.
About:
L U C I R A H E A L T H
Series B (1/16/2020)
$17.5M
Latest Round:
Amount:
Lucira Health develops
disposable point-of-care
molecular tests for diagnosing
infectious diseases.
About:
M A M M O T H B I O S C I E N C E S
Series B (1/30/2020)
$45M
Latest Round:
Amount:
Mammoth has developed a
CRISPR data platform for
diagnostics, which it claims
returns results within one hour
and does not require expensive
equipment or electricity.
About:
41. 51
H I G H L I G H T # 3 : D I A L Y S I S A N Y W H E R E
Outset Medical raised $125M and got FDA clearance
Series E (2/4/2020)
$125M
T. Rowe Price, Fidelity Investments, Perceptive
Advisors, Partner Fund Management, and D1
Capital Partners
Outset Medical has developed a dialysis machine that
purifies its own water and generates dialysate. It aims to
help patients manage their own treatments from any
location. Outset's Tablo Hemodialysis System is intended to
lower costs for dialysis providers and improve the care
experience for patients.
Latest Round:
Amount:
Select Round
Investors:
About:
42. 52
GLOBAL HEALTHCARE REPORT Q1'20
WOMEN’S
HEALTH
AI
MEDICAL
DEVICES
MENTAL
HEALTH
TELEHEALTH
DIGITAL
HEALTH
IN CHINA
REGENERATIVE
MEDICINE
HEALTHCARE Q1 2020
43. 53
Q1’20 deal volume reached the lowest level since Q2’17
D I G I T A L H E A L T H I N C H I N A D E A L S A N D D O L L A R S
Digital health in China funding and deal count, Q2’17 – Q1’20
$167 $288 $610 $845 $1,224 $857 $338 $713 $1,768 $498 $659 $318
25
41
53
49
69
60
56
38
44 44
55
27
-
10
20
30
40
50
60
70
80
$-
$200
$400
$600
$800
$1,000
$1,200
$1,400
$1,600
$1,800
$2,000
Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20
Amount ($M) Deal Count
44. 55
H I G H L I G H T # 2 : V I R T U A L C A R E D E L I V E R Y C O R A I S E D T H E L A R G E S T R O U N D
Zhangshang Tangyi raised the largest deal in Q1’20
Series D (1/8/2020)
$143.9M
Samsung Electronics, SIG Asia
Investments, CMB International
Capital, Talsy Capital, Bojiang Capital,
CEC Data Capital
About: Zhangshang Tangyi (Literal translation:
Mobile Sugar Doctor) is a mobile diabetes
management app that allows patients to record their
own health data by connecting to glucose monitors,
communicating with providers, and accessing
educational content. The company also operates an
e-commerce platform where patients can buy
diabetes devices and supplies.
Latest Round:
Amount:
Select Round
Investors:
45. 56
Startups now focus on a broad range of use cases
H I G H L I G H T # 3 : H E A L T H C A R E P A Y M E N T S R E M A I N I N V O G U E
Series A (2/28/2020)
Undisclosed
Latest Round:
Amount:
Incubated by the public insurer
ZhongAn, Nuanwa offers services
to health insurers across benefit
design, underwriting, and care
management.
About:
G R O U P H E A L T H
I N S U R A N C E P L A T F O R M
Series C (3/18/2020)
$25.0M
Latest Round:
Amount:
Insgeek partners with Chinese
SMEs to select and design group
health insurance products. The
company also offers a SaaS
product for SMEs to manage
healthcare benefits.
About:
D R U G & D I A G N O S T I C S
A C C E S S S O L U T I O N S
Unattributed (3/10/2020)
Undisclosed
Latest Round:
Amount:
MediTrust serves specialty drug
manufacturers and diagnostics
companies. It provides patient
affordability services and also
offers a PBM solution to health
insurers.
About:
H E A L T H I N S U R E R
I N F R A S T R U C T U R E
Insgeek Cloud
Insurance Platform
(Nuanwa Technology)
(Insgeek)
• Buying and managing employee
insurance online
• Flexible premium payment options,
support payments in installment
• Flexible covered lives, premium
calculated by days
Pharmacies in 200+
Cities
100,000+ Patients
20+ Payment programs
46. 57
GLOBAL HEALTHCARE REPORT Q1'20
WOMEN’S
HEALTH
AI
MEDICAL
DEVICES
MENTAL
HEALTH
TELEHEALTH
DIGITAL
HEALTH
IN CHINA
REGENERATIVE
MEDICINE
47. 58
$66 $225 $249 $44 $128 $451 $97 $477 $304 $261 $144 $361
23
34
31
23
38
45
29
48
40
47
32 31
-
5
10
15
20
25
30
35
40
45
50
55
$-
$50
$100
$150
$200
$250
$300
$350
$400
$450
$500
Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20
Q1’20 funding increased by 150% quarter-over-quarter
W O M E N ’ S H E A L T H D E A L S A N D D O L L A R S
Women’s health funding and deal count, Q2’17 – Q1’20
Amount ($M) Deal Count
48. 59
Top deals in women’s health emphasize telemedicine
H I G H L I G H T # 1 : I N C R E A S I N G A C C E S S T H R O U G H V I R T U A L C A R E
M A V E N C L I N I C A D V A N T I A H E A L T H
Series C (2/19/2020) $45MLatest Round: Amount:
Maven Clinic offers a digital health clinic for
women and families. It offers its virtual
healthcare services for individuals, employers,
and health plans. Its Series C round was led by
Icon Ventures, with other participating investors
including Sequoia Capital and Oak HC/FT.
About:
Series C (1/8/2020) $45MLatest Round: Amount:
Advantia Health offers both in-person and virtual
care for women through its network of OB-GYN
and specialist providers. In April 2019, it
acquired the post-partum telemedicine platform
Pacify. Its Series C funding came from
BlueMountain Capital Management.
About:
49. 60
Diagnostics options for pregnant women grow
H I G H L I G H T # 2 : A N E M P H A S I S O N E A R L Y S C R E E N I N G
P R E - T E R M R I S K
Series E (2/27/2020)
$15.8M
Latest Round:
Amount:
Sera Prognostics offers a test
for risk management, which
aims to predict a woman’s
risk of preterm birth and other
pregnancy complications.
About:
C A R R I E R S C R E E N I N G
Series A (3/10/2020)
$15M
Latest Round:
Amount:
BillionToOne has developed a
prenatal test that screens
fetal cell-free DNA for 5
commonly inherited
conditions.
About:
E A R L Y T E S T I N G
Loan (2/19/2020)
$6M
Latest Round:
Amount:
Cradle Genomics is
developing a comprehensive
prenatal test that aims to
provide insights during the
first trimester.
About:
50. 62
GLOBAL HEALTHCARE REPORT Q1'20
WOMEN’S
HEALTH
AI
MEDICAL
DEVICES
MENTAL
HEALTH
TELEHEALTH
DIGITAL
HEALTH
IN CHINA
REGENERATIVE
MEDICINE
HEALTHCARE Q1 2020
51. 63
$137 $160 $76 $177 $247 $129 $125 $210 $357 $225 $115 $576
23
28
22
33 33
30
22
42 41
52
37
44
-
5
10
15
20
25
30
35
40
45
50
55
$-
$100
$200
$300
$400
$500
$600
Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20
Funding to the space reached a record high in Q1’20
M E N T A L H E A L T H D E A L S A N D D O L L A R S
Mental health funding and deal count, Q2’17 – Q1’20
Amount ($M) Deal Count
52. 64
Mental health product offerings for employers grow
H I G H L I G H T # 1 : M O R E E M P L O Y E R S O L U T I O N S
L Y R A H E A L T H
Series C (3/11/2020)
$75M
Latest Round:
Amount:
Lyra Health offers a mental
health platform based on
evidence-based treatments.
About:
M O D E R N H E A L T H
Series B (1/15/2020)
$31M
Latest Round:
Amount:
Modern Health offers a suite of
mental health solutions
comprised of digital programs,
virtual coaching, and clinical
therapy.
About:
S P R I N G H E A L T H
Series A (1/24/2020)
$22M
Latest Round:
Amount:
Spring Health provides a platform
which emphasizes a data-driven
approach to delivering
individualized care.
About:
53. 66
Applying virtual reality to treat mental health conditions
H I G H L I G H T # 3 : V R S T A R T U P S P I C K U P E A R L Y S T A G E I N V E S T M E N T S
O X F O R D V R C 2 C A R E
Series A (2/12/2020) $13MLatest Round: Amount:
UK-based Oxford VR offers a clinically validated
virtual reality platform to treat mental health
patients. In July 2019, it partnered with the
National Mental Health Innovation Center
(NMHIC) to conduct pilots. Its Series A financing
was led by Optum Ventures and will be used to
expand in the US.
About:
Seed (1/13/2020) $1.1MLatest Round: Amount:
France-based C2Care offers a virtual reality
platform for healthcare professionals, including
those practicing in mental health. Current
applications include treating anxieties,
addictions, and eating disorders. The company
plans to continue its development and expand
internationally.
About:
54. 67
GLOBAL HEALTHCARE REPORT Q1'20
WOMEN’S
HEALTH
AI
MEDICAL
DEVICES
MENTAL
HEALTH
TELEHEALTH
DIGITAL
HEALTH
IN CHINA
REGENERATIVE
MEDICINE
55. 68
$638 $644 $811 $1,912 $1,962 $1,813 $1,087 $1,010 $1,545 $1,335 $1,090 $1,876
46
51 53 55
85
62
52
43
71
60 61
66
-
10
20
30
40
50
60
70
80
90
$-
$500
$1,000
$1,500
$2,000
$2,500
Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20
Funding rose by more than 70% since Q4’19
R E G E N E R A T I V E M E D I C I N E D E A L S A N D D O L L A R S
Regenerative medicine funding and deal count, Q2’17 – Q1’20
Amount ($M) Deal Count
56. 69
Company Deal Date //
Amount Raised
Total Disclosed
Funding
Select Investors Description
IO deals among the largest in regenerative med space
H I G H L I G H T # 1 : M E G A - R O U N D S A B O U N D I N I M M U N O - O N C O L O G Y ( I O )
Mar’20 //
$170M
Mar’20 //
$493M
Mar’20 //
$100.5M
Feb’20 //
$105M
Feb’20 //
$98M
$320.0M
$851.0M
$130.5M
$123.0M
$170.0M
MPM Capital, Vertex Ventures, F2 Ventures, EcoR1
Capital
N/A
Takeda Ventures, SV Health Investors, F-Prime
Capital, MRL Ventures Fund
Vivo Capital, HBM Healthcare Investments,
Lightstone Ventures, Foresite Capital
General Atlantic, WuXi AppTec, Hudson Bay
Capital Management, YuanMing Capital
Elevate Bio has a portfolio of cell and gene
therapy companies.
Lyell Immunopharma develops cell-based
immunotherapies for cancer, with a focus on solid
tumors.
Xilio Therapeutics develops tumor-selective
immunotherapies designed to act at the site of
the tumor.
ALX Oncology develops immuno-oncology
therapies.
China-based CANbridge Life Sciences offers
specialty products in China and North Asia,
including cancer immunotherapy products.
57. 71
Different applications of stem cells emerge
H I G H L I G H T # 3 : S T E M C E L L A P P L I C A T I O N S
C O N D I T I O N I N G A G E N T S
Series A (1/9/2020)
$14.1M
Latest Round:
Amount:
Jasper Therapeutics develops
conditioning agents for safer,
more effective stem cell
transplants.
About:
N O N - A G I N G S T E M C E L L S
Series A (3/17/2020)
$8M
Latest Round:
Amount:
South Korea-based ENCell
develops stem cells where
aging is suppressed to
preserve functions.
About:
T H E R A P E U T I C S
Unattributed (1/10/2020)
$5M
Latest Round:
Amount:
Tactitus Therapeutics
develops stem cell therapies
for blood cancers.
About:
58. The image part with relationship ID rId2 was not found in the file.
#AhaCBI
Most Active
Healthcare VCs
In Q1’20
59. 73
The most active healthcare VCs in Q1'20
By unique healthcare company investments (new or follow-on)
Rank Investor HQ Country Q1'20 Healthcare Investments
1
2
2
4
4
6
6
Excludes incubators/accelerators Y Combinator (34 deals), Techstars (10 deals), and SOSV (8 deals).
60. 74
The most active healthcare VCs in Q1'20
By unique healthcare company investments (new or follow-on)
Rank Investor HQ Country Q1'20 Healthcare Investments
6
6
6
6
(NewMed Medical)
*
Excludes incubators/accelerators like Y Combinator (34 deals), Techstars (10 deals), and SOSV (8 deals). *A logo for Affinia Therapeutics could not be found.
61. The image part with relationship ID rId2 was not found in the file.
#AhaCBI
Most Active
Digital Health
VCs In Q1’20
62. 76
The most active digital health VCs in Q1'20
By unique digital health company investments (new or follow-on)
Rank Investor HQ Country Q1'20 Healthcare Investments
1
2
2
4
4